Danaher (DHR) Competitors $200.70 +1.07 (+0.54%) Closing price 07/8/2025 03:59 PM EasternExtended Trading$200.25 -0.45 (-0.22%) As of 07:34 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DHR vs. RGEN, A, CR, CSL, GFF, IQV, MTD, TMO, MMM, and ELVShould you be buying Danaher stock or one of its competitors? The main competitors of Danaher include Repligen (RGEN), Agilent Technologies (A), Crane (CR), Carlisle Companies (CSL), Griffon (GFF), IQVIA (IQV), Mettler-Toledo International (MTD), Thermo Fisher Scientific (TMO), 3M (MMM), and Elevance Health (ELV). Danaher vs. Its Competitors Repligen Agilent Technologies Crane Carlisle Companies Griffon IQVIA Mettler-Toledo International Thermo Fisher Scientific 3M Elevance Health Danaher (NYSE:DHR) and Repligen (NASDAQ:RGEN) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation. Is DHR or RGEN more profitable? Danaher has a net margin of 15.81% compared to Repligen's net margin of -3.93%. Danaher's return on equity of 10.80% beat Repligen's return on equity.Company Net Margins Return on Equity Return on Assets Danaher15.81% 10.80% 6.89% Repligen -3.93%4.53%3.17% Which has more risk & volatility, DHR or RGEN? Danaher has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Comparatively, Repligen has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. Do institutionals and insiders have more ownership in DHR or RGEN? 79.1% of Danaher shares are owned by institutional investors. Comparatively, 97.6% of Repligen shares are owned by institutional investors. 11.2% of Danaher shares are owned by insiders. Comparatively, 1.2% of Repligen shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Do analysts prefer DHR or RGEN? Danaher presently has a consensus target price of $248.00, suggesting a potential upside of 23.57%. Repligen has a consensus target price of $170.75, suggesting a potential upside of 32.82%. Given Repligen's higher probable upside, analysts plainly believe Repligen is more favorable than Danaher.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Danaher 0 Sell rating(s) 4 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 2.80Repligen 0 Sell rating(s) 4 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.69 Which has higher valuation & earnings, DHR or RGEN? Danaher has higher revenue and earnings than Repligen. Repligen is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDanaher$23.88B6.02$3.90B$5.1538.97Repligen$634.44M11.38-$25.51M-$0.45-285.69 Does the media favor DHR or RGEN? In the previous week, Danaher had 46 more articles in the media than Repligen. MarketBeat recorded 56 mentions for Danaher and 10 mentions for Repligen. Danaher's average media sentiment score of 1.54 beat Repligen's score of 0.82 indicating that Danaher is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Danaher 51 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Very Positive Repligen 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryDanaher beats Repligen on 12 of the 16 factors compared between the two stocks. Get Danaher News Delivered to You Automatically Sign up to receive the latest news and ratings for DHR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DHR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DHR vs. The Competition Export to ExcelMetricDanaherMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$142.87B$7.24B$5.47B$20.52BDividend Yield0.64%2.83%5.25%3.78%P/E Ratio38.9727.3326.9927.79Price / Sales6.0234.17428.7140.41Price / Cash18.2723.6936.8222.26Price / Book2.936.727.984.58Net Income$3.90B$230.16M$3.16B$982.91M7 Day Performance-0.88%1.12%2.38%0.41%1 Month Performance0.72%2.31%2.17%3.59%1 Year Performance-16.31%49.95%33.81%14.47% Danaher Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DHRDanaher4.8894 of 5 stars$200.70+0.5%$248.00+23.6%-16.6%$142.87B$23.88B38.9763,000Positive NewsAnalyst ForecastRGENRepligen4.7914 of 5 stars$124.24+0.6%$172.83+39.1%+7.3%$6.98B$634.44M-276.091,778Analyst ForecastAAgilent Technologies4.7245 of 5 stars$118.22-0.8%$140.92+19.2%-3.9%$33.58B$6.51B29.1918,100Positive NewsAnalyst ForecastCRCrane3.3494 of 5 stars$188.81+0.2%$197.75+4.7%+34.5%$10.86B$2.18B25.0111,000Trending NewsCSLCarlisle Companies4.2182 of 5 stars$374.53+0.1%$461.67+23.3%-2.1%$16.20B$5.00B13.945,500GFFGriffon4.9547 of 5 stars$72.14-0.7%$98.20+36.1%+22.2%$3.39B$2.62B14.945,300IQVIQVIA4.8948 of 5 stars$157.50+0.0%$226.32+43.7%-21.2%$27.25B$15.41B21.4686,000Positive NewsMTDMettler-Toledo International4.3319 of 5 stars$1,172.22-1.0%$1,300.36+10.9%-9.3%$24.36B$3.87B29.2318,000Positive NewsAnalyst ForecastTMOThermo Fisher Scientific4.9916 of 5 stars$404.86-0.8%$604.05+49.2%-20.4%$152.83B$42.88B23.75125,000Positive NewsAnalyst ForecastMMM3M4.2021 of 5 stars$152.07+0.0%$155.83+2.5%+52.0%$81.84B$24.58B19.2092,000Positive NewsELVElevance Health4.9548 of 5 stars$388.91+1.9%$498.87+28.3%-33.7%$87.87B$183.12B15.17102,300Trending News Related Companies and Tools Related Companies RGEN Alternatives A Alternatives CR Alternatives CSL Alternatives GFF Alternatives IQV Alternatives MTD Alternatives TMO Alternatives MMM Alternatives ELV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:DHR) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Danaher Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Danaher With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DHR Stock Alerts